| Item Type | Name |
|
Concept
|
Combined Modality Therapy
|
|
Concept
|
Drug Therapy, Combination
|
|
Concept
|
Embolization, Therapeutic
|
|
Concept
|
Chemoembolization, Therapeutic
|
|
Concept
|
Treatment Outcome
|
|
Concept
|
Molecular Targeted Therapy
|
|
Concept
|
Neoadjuvant Therapy
|
|
Academic Article
|
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
|
|
Academic Article
|
Non-alcoholic fatty liver disease: is bariatric surgery the answer?
|
|
Academic Article
|
Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir.
|
|
Academic Article
|
Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience.
|
|
Academic Article
|
Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.
|
|
Academic Article
|
Caution: Reactivation of Hepatitis B during Hepatitis C Treatment with Direct-Acting Antiviral Therapy.
|
|
Academic Article
|
Treatment of HCV infection in liver transplant recipients with ledipasvir and sofosbuvir without ribavirin.
|
|
Academic Article
|
Liver Transplantation in the Obese Cirrhotic Patient.
|
|
Academic Article
|
Goals and targets for personalized therapy for HCC.
|
|
Academic Article
|
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
|
|
Academic Article
|
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma.
|
|
Academic Article
|
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.
|
|
Academic Article
|
Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
|
|
Academic Article
|
Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years?
|
|
Academic Article
|
Probiotics for treatment of Clostridium difficile-associated colitis in adults.
|
|
Academic Article
|
Yttrium-90 Radioembolization Therapy for Combined Hepatocellular and Cholangiocarcinoma.
|
|
Academic Article
|
Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
|
|
Academic Article
|
Safety and efficacy of repeat Y90 radioembolization to the same hepatic arterial territory.
|
|
Academic Article
|
Living Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes, and Factors Associated With Outcomes.
|
|
Academic Article
|
Factors associated with sustained virological response in liver transplant recipients with recurrent hepatitis C.
|
|
Academic Article
|
Update on the Diagnosis and Treatment of Hepatocellular Carcinoma.
|
|
Academic Article
|
The effect of COVID-19 on liver transplantation: impact, practice patterns, therapeutics, and next steps.
|
|
Academic Article
|
Recent Advances in Hepatocellular Carcinoma Treatment.
|
|
Academic Article
|
Systemic Therapy for Hepatocellular Carcinoma.
|
|
Academic Article
|
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice.
|
|
Academic Article
|
Twenty Years of Radiation Therapy of Unresectable Intrahepatic Cholangiocarinoma: Internal or External? A Systematic Review and Meta-Analysis.
|
|
Academic Article
|
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma.
|
|
Academic Article
|
Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma.
|
|
Academic Article
|
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
|
|
Academic Article
|
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study.
|
|
Academic Article
|
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
|
|
Academic Article
|
Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma.
|
|
Academic Article
|
Yttrium-90 Radioembolization and Concomitant Systemic Gemcitabine, Cisplatin, and Capecitabine as the First-Line Therapy for Locally Advanced Intrahepatic Cholangiocarcinoma.
|
|
Academic Article
|
Living donor liver transplantation: A multi-disciplinary collaboration towards growth, consensus, and a change in culture.
|
|
Academic Article
|
A survey of transplant providers regarding attitudes, barriers, and facilitators to living donor liver transplantation in the United States.
|
|
Academic Article
|
Evolving challenges with long-term care of liver transplant recipients.
|
|
Academic Article
|
Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience.
|
|
Academic Article
|
Contemporary applications of Y90 for the treatment of hepatocellular carcinoma.
|
|
Academic Article
|
Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma.
|
|
Academic Article
|
Current updates in HCC screening and treatment.
|
|
Academic Article
|
Management of Intermediate-Stage Hepatocellular Carcinoma: Systemic Versus Locoregional Therapy.
|
|
Academic Article
|
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma.
|
|
Academic Article
|
Tumor Size and Watershed Area Correlate with Incomplete Treatment and Tumor Progression after Selective Radioembolization for Hepatocellular Carcinoma.
|
|
Academic Article
|
Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysis.
|
|
Academic Article
|
Modified Radiation Lobectomy Strategy of Radioembolization for Right-Sided Unresectable Primary Liver Tumors.
|
|
Academic Article
|
Considerations in gender-affirming hormone therapy in transgender and gender diverse patients undergoing liver transplantation.
|
|
Academic Article
|
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future.
|
|
Academic Article
|
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment.
|
|
Academic Article
|
Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma.
|